• A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: an expert panel consensus 

      Farmakis, Dimtrios; Agostoni, Piergiuseppe; Baholli, Loant; Bautin, Andrei; Comin-Colet, Josep; Crespo-Leiro, María Generosa; Fedele, Francesco; García-Pinilla, José Manuel; Giannakoulas, George; Grigioni, Francesco; Gruchała, Marcin; Gustafsson, Finn; Harjola, Veli-Pekka; Hasin, Tal; Herpain, Antoine; Iliodromitis, Efstathios K.; Karason, Kristjan; Kivikko, Matti; Liaudet, Lucas; Ljubas-Maček, Jana; Marini, Marco; Masip, Josep; Mebazaa, Alexandre; Nikolaou, Maria; Ostadal, Petr; Põder, Pentti; Pollesello, Piero; Polyzogopoulou, Eftihia; Pölzl, Gerhard; Tschope, Carsten; Varpula, Marjut; Lewinski, Dirk von; Vrtovec, Bojan; Yilmaz, Mehmet Birhan; Zima, Endre; Parissis, John (Elsevier, 2019-12-15)
      [Abstract] Inotropes aim at increasing cardiac output by enhancing cardiac contractility. They constitute the third pharmacological pillar in the treatment of patients with decompensated heart failure, the other two being ...
    • Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION‐HEART multicentre randomised trial 

      Comín-Colet, Josep; Manito, Nicolás; Segovia-Cubero, Javier; Delgado Jiménez, Juan Francisco; García-Pinilla, José Manuel; Almenar, Luis; Crespo-Leiro, María Generosa; Sionis, Alessandro; Blasco, Teresa; Pascual Figal, Domingo A.; González-Vílchez, Francisco; Lambert Rodríguez, José Luis; Grau, María; Bruguera, Jordi (Wiley, 2018)
      [Abstract] Aims. The LION‐HEART study was a multicentre, double‐blind, randomised, parallel‐group, placebo‐controlled trial evaluating the efficacy and safety of intravenous administration of intermittent doses of levosimendan ...